Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Choosing an index fund involves evaluating costs, tracking accuracy, and liquidity. This quick guide highlights essential factors to help you select wisely.
19,450 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Starting with little cash and limited credit? Discover actionable tactics to find fund your first real estate deal, f...
A big star leaving a major project isn’t just showbiz drama. It’s a real-world reminder to guard your finances with a...
A big fund trimmed its ACMR stake, yet the stock jumped 170% in a short window. This article breaks down what happene...
A recent SEC filing shows Brightlight Capital trimmed its Hilton stake by 79,500 shares, reducing the position's valu...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
A momentum-driven small-cap ETF with about $2.2 billion in assets again outpaced major benchmarks, drawing investor a...
A major move in the ETF world: Security Financial Services opens a substantial CORO stake. This article breaks down w...
As bond markets evolve, a widely used bond ETF faces renewed scrutiny over cost and hedging power. Investors are aske...
When a stock stalls, a disciplined fund can still see value in the long run. This article explains why this fund made...
Tesla commands a large slug of XLY, giving the fund a distinct risk/reward profile compared with VCR. In the past fiv...
CWB blends income with potential equity upside, but its behavior shifts from bond-like to stock-like in market downtu...